Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers
about
Intensified surveillance for early detection of breast cancer in high-risk patientsCardiovascular Disease in Women: Clinical Perspectives.A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian CancerAn international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy.Pathologic findings at risk-reducing salpingo-oophorectomy (RRSO) in germline BRCA mutation carriers with breast cancer: significance of bilateral RRSO at the optimal age in germline BRCA mutation carriers.Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations.Adaptation of couples living with a high risk of breast/ovarian cancer and the association with risk-reducing surgery.Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.Nipple-sparing mastectomy in women at high risk of developing breast cancer.
P2860
Q30392157-0D48C91B-80C6-4A4B-9976-6063D585C8EDQ30743765-67E76ACC-2A4F-4701-82BC-077D36D3AAF5Q33606561-6F35BC3F-FD73-4D00-9E05-E8FDB7B5F06AQ33901361-95A3E5F1-1A3D-4CEA-AA76-E651BD340E56Q36240959-0ED574FD-473A-4BA3-A86F-BC9D7F41A01AQ37512375-8381E4A4-FED1-481A-A354-DC4C9B33B78EQ38851169-F81B9546-1B61-4219-8A1D-191ED96E05FDQ46581570-DB92DD0B-0170-44E9-B51A-C1C47E1CBF4CQ47235402-E4E8C157-80E2-4CC7-948F-4623A5413B26Q47568815-1706F7E9-4C7C-4B56-B985-2FAE232801AEQ47585612-86F81F72-FECE-4C47-82BC-AF3AF0C3BE2CQ49615943-0EA84067-9509-40B7-B53D-46C7BD16C0DDQ55603054-2B819DD5-187B-4C44-914C-AAC00DF27BD8
P2860
Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@ast
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@en
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@nl
type
label
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@ast
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@en
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@nl
prefLabel
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@ast
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@en
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@nl
P2093
P2860
P50
P1476
Use of risk-reducing surgeries ...... A1 and BRCA2 mutation carriers
@en
P2093
Christian F Singer
Ellen Matloff
Gail Tomlinson
Henry T Lynch
Jinbo Chen
Joanne L Blum
Judy E Garber
Mary B Daly
Nadine Tung
Patricia A Ganz
P2860
P2888
P304
P356
10.1007/S10549-014-3134-0
P407
P50
P577
2014-10-14T00:00:00Z
P5875
P6179
1002068661